Ligand PharmaceuticalsLGND
那斯達克 · USD
290.02
+1.19
(+0.41%)
盤中 09/10 02:23 (UTC+8)
09/10 02:23 (UTC+8)
Ligand PharmaceuticalsLGND
290.02
+1.19
(+0.41%)
財務數據
損益表
- 0.31
- 0.42
- 0.52
- 0.43
- 0.45
- 0.48
- 1.15
- 0.60
- 0.52
- 0.64
- 10.24
- 34.07
- 24.76
- -17.37
- 5.89
- 5.06
- 142.43
- -48.32
- -13.31
- 23.14
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | 63,693 | 51,722 | 59,666 | 115,461 | 47,627 | 45,333 | 42,812 | 51,812 | 41,531 | 30,978 |
營業成本 | 3,214 | 3,273 | 2,992 | 3,801 | 2,907 | 4,849 | 2,837 | 2,449 | 2,906 | 2,882 |
營業毛利 | 60,479 | 48,449 | 56,674 | 111,660 | 44,720 | 40,484 | 39,975 | 49,363 | 38,625 | 28,096 |
營業費用 | 51,888 | 31,081 | 42,831 | 56,729 | 36,276 | 76,700 | 49,612 | - | - | 25,108 |
研發費用 | 14,668 | 2,148 | 3,511 | 21,019 | 6,567 | 50,085 | 4,425 | 5,675 | 5,354 | 5,971 |
推銷及管理費用 | 29,123 | 20,836 | 25,027 | 27,613 | 21,451 | 18,358 | 32,848 | 32,287 | 17,623 | 10,951 |
非經常性項目費用 | - | - | 6,197 | - | - | - | 4,081 | - | 26,491 | - |
其他營業費用 | 8,097 | 8,097 | 8,096 | 8,097 | 8,258 | 8,257 | 8,258 | 8,258 | 8,257 | 8,186 |
營業利益 | 8,591 | 17,368 | 20,040 | 54,931 | 8,444 | -36,216 | -9,637 | 3,143 | -19,100 | 2,988 |
其他收入及費用 | 21,734 | 9,349 | 29,939 | 11,229 | 3,932 | -13,097 | -63,281 | -8,739 | -45,020 | 110,600 |
利息費用 | 1,748 | 1,747 | 1,785 | 910 | 1,153 | 867 | 883 | 743 | 1,270 | 141 |
稅前純益 | 64,304 | -24,259 | 56,780 | 141,137 | 11,223 | -50,180 | -39,200 | -6,339 | -65,390 | 113,447 |
所得稅 | 15,796 | -10,914 | 11,996 | 23,864 | 6,376 | -7,729 | -8,112 | 833 | -13,479 | 27,308 |
稅後純益 | 48,508 | -13,345 | 44,784 | 117,273 | 4,847 | -42,451 | -31,088 | -7,172 | -51,911 | 86,139 |
基本每股稅後盈餘(元) | 2.42 | -0.67 | 2.27 | 5.99 | 0.25 | -2.21 | -1.64 | -0.39 | -2.88 | 4.86 |
稀釋每股稅後盈餘(元) | 2.30 | -0.67 | 2.18 | 5.68 | 0.26 | -2.21 | -1.68 | -0.41 | -2.88 | 4.75 |
基本平均股數(千股) | 20063.00 | 19883.00 | 19726.00 | 19578.00 | 19327.00 | 19191.00 | 18974.00 | 18419.00 | 18028.00 | 17732.00 |
稀釋平均股數(千股) | 21837.00 | 19883.00 | 21138.00 | 20629.00 | 19926.00 | 19191.00 | 18974.00 | 18419.00 | 18028.00 | 18122.00 |
還原基本每股稅後盈餘(元) | 2.42 | -0.67 | 2.27 | 5.99 | 0.25 | -2.21 | -1.64 | -0.39 | -2.88 | 4.86 |
還原稀釋每股稅後盈餘(元) | 2.30 | -0.67 | 2.18 | 5.68 | 0.26 | -2.21 | -1.68 | -0.41 | -2.88 | 4.75 |
還原基本平均股數(千股) | 20,063 | 19,883 | 19,726 | 19,578 | 19,327 | 19,191 | 18,974 | 18,419 | 18,028 | 17,732 |
還原稀釋平均股數(千股) | 21,837 | 19,883 | 21,138 | 20,629 | 19,926 | 19,191 | 18,974 | 18,419 | 18,028 | 18,122 |
EBITDA(千元) | 74,371 | -14,516 | 65,809 | 149,904 | 20,669 | -40,675 | -29,553 | 3,967 | -55,097 | 122,758 |